The estÉe lauder companies highlights key epigenetics & multi-ethnic translational clinical research at 33rd ifscc congress

Data presented underscore elc r&d's leadership in skin longevity and its work to advance optimal skin innovation methodologies that are inclusive of ethnic differences new york , oct. 12, 2023 /prnewswire/ -- the estÉe lauder companies inc. (elc) (nyse: el) shared its latest clinical research findings in an invited keynote address and podium presentation at the 33rd international federation of societies of cosmetic chemists (ifscc) congress, held in barcelona, spain, in september. nadine pernodet, phd, senior vice president, bioscience, elc, and estÉe lauder brand lead scientist, addressed innovation in the beauty industry in a lecture entitled, "harnessing epigenetics: from anti-aging to age reversal.
EL Ratings Summary
EL Quant Ranking